News
-
-
-
COMMUNIQUÉ DE PRESSE
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
PharmaSGP surpasses €100 million revenues in 2023, plans growth in 2024. Achieved 17.8% revenue increase and 20.8% rise in adjusted EBITDA. Forecasts €107-112 million revenues and €35-38 million EBITDA for 2024 -
COMMUNIQUÉ DE PRESSE
PharmaSGP achieves top performance in the first half of 2023
-
-
-
COMMUNIQUÉ DE PRESSE
PharmaSGP plans dividend distribution of 49.2% after record year in 2022
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: PharmaSGP Holding SE releases forecast for full year 2023
-